Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis

Background Bivalirudin may be an effective alternative anticoagulant to heparin for use in percutaneous peripheral interventions. We aimed to compare the safety and efficacy of bivalirudin versus heparin as the procedural anticoagulant agent in patients undergoing percutaneous peripheral interventio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vascular 2019-02, Vol.27 (1), p.78-89
Hauptverfasser:	Olmedo, Wilman, Villablanca, Pedro A, Sanina, Cristina, Walker, Jonathan, Weinreich, Michael, Brevik, Jeannine, Avendano, Ricardo, Bravo, Claudio A, Romero, Jorge, Ramakrishna, Harish, Babaev, Anvar, Attubato, Michael, Hernandez-Suarez, DF, Cox-Alomar, P, Pyo, Robert, Krishnan, Prakash, Wiley, Jose
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Antithrombins - administration & dosage Antithrombins - adverse effects Catheterization, Peripheral - adverse effects Catheterization, Peripheral - mortality Endovascular Procedures - adverse effects Endovascular Procedures - mortality Female Hemorrhage - chemically induced Heparin - administration & dosage Heparin - adverse effects Hirudins - administration & dosage Hirudins - adverse effects Humans Male Peptide Fragments - administration & dosage Peptide Fragments - adverse effects Peripheral Arterial Disease - therapy Recombinant Proteins - administration & dosage Recombinant Proteins - adverse effects Risk Assessment Risk Factors Thrombosis - etiology Thrombosis - mortality Thrombosis - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!